US equities
|
MU
$1,067.06
▼-0.73%
NVDA
$235.46
▲+0.65%
INTC
$115.78
▼-2.98%
AMD
$621.85
▼-1.90%
META
$731.46
▲+0.46%
TSLA
$366.74
▼-1.04%
SPCX
$158.94
▼-0.01%
PTC
$195.75
▲+35.91%
MU
$1,067.06
▼-0.73%
NVDA
$235.46
▲+0.65%
INTC
$115.78
▼-2.98%
AMD
$621.85
▼-1.90%
META
$731.46
▲+0.46%
TSLA
$366.74
▼-1.04%
SPCX
$158.94
▼-0.01%
PTC
$195.75
▲+35.91%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
PepGen Inc. - Common Stock
(NQ:
PEPG
)
2.300
+0.020 (+0.88%)
Delayed Quote
Updated: 9:30 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PepGen Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG
June 18, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG
June 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, Tempus, and Rocket and Encourages Investors to Contact the Firm
June 16, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Lifshitz Law PLLC Announces Investigations of Fortrea Holdings, Inc. (NASDAQ: FTRE), Vestis Corporation (NYSE: VSTS), PepGen Inc. (NASDAQ: PEPG) and Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT)
June 16, 2025
Via
ACCESS Newswire
PEPGEN INC. (NASDAQ: PEPG) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds PepGen Inc. Investors of Upcoming Deadline
June 16, 2025
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG
June 15, 2025
From
Pomerantz LLP
Via
GlobeNewswire
PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit With Faruqi & Faruqi, LLP
June 13, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against PepGen, Inc. and Encourages Investors to Contact the Firm
June 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
June 11, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 10, 2025
From
The Schall Law Firm
Via
Business Wire
Rosen Law Firm Urges PepGen Inc. (NASDAQ: PEPG) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
June 10, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
June 10, 2025
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG
June 10, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
↗
June 06, 2025
Via
Benzinga
PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate
↗
May 29, 2025
PepGen ends Duchenne drug program after weak Phase 2 results, pivots to DM1 treatment showing early signs of splicing correction and safety.
Via
Benzinga
PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update
May 28, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer
May 20, 2025
From
PepGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 16, 2025
Via
Benzinga
PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 08, 2025
From
PepGen Inc.
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 25, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
April 22, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 21, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 17, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 12, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 07, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
April 03, 2025
From
Pomerantz LLP
Via
GlobeNewswire
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
April 02, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces Appointment of Two New Directors to its Board
March 31, 2025
From
PepGen Inc.
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
March 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
March 26, 2025
From
Pomerantz LLP
Via
GlobeNewswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
